• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
How soon does a body start to reject an allograft?
Immediately, the body accepts the graft. After 10-13 days, however, the body begins to reject the graft.
If you put a second transplant into a person, how soon after will the body reject the graft?
Almost immediately b/c the immune system was primed.
Which MHC molecule is the MAJOR player in graft rejection?
Type I, type II can affect, but isn't as rapid.
Which immune cells are responsible for the rapid rejection of the transplant of a second organ into a patient?
T cells
What are the two paths to transplant rejection?
Direct allorecognition (Donor Dendritic cell Depletion) and Indirect allorecognition (the recipient mounts a new immune response).
Explain Direct allorecognition
Donor dendritic cells go straight to the recipient's lymph nodes and present Ag, stimulating recipient T cells. Acute rejection occurs very, very quickly b/c the APCs were primed and ready to go.
Explain Indirect allorecognition
Recipient APCs process and present graft Ag. This is slower than direct allorecogntion.
When does hypeacute graft rejection occur? How do you prevent it?
when their is preexisting Ab to donor graft blood Ags. Typically occurs when their was a previous blood transfusion. Cross match Ab in whole blood b/t donor and recipient.
What happens in graft vs. host disease? How do you prevent this?
if HLA type isn't matched, when a immunocompetent donor lymphocytes (from bone marrow transplant e.g.) reject recipient tissue.
What two factors determine transplant success?
HLA (MHC) matching and immunosuppressive therapy.